Table 2.
Study | Tick strain | Daya | Placebob | Simparica Trio™b | % Efficacy | Test statistic | ||
---|---|---|---|---|---|---|---|---|
Mean | Range | Mean | Range | |||||
3 | Oklahoma State Universityc | 2 | 30.0 | 3–74 | 0 | 0–0 | 100 | t(9) = 4.78, P = 0.0010 |
7 | 33.8 | 14–50 | 0.1 | 0–1 | 99.7 | t(9) = 8.12, P < 0.0001 | ||
14 | 30.1 | 15–44 | 0.1 | 0–1 | 99.7 | t(9.02) = 10.61, P < 0.0001 | ||
21 | 32.6 | 12–47 | 0.2 | 0–2 | 99.4 | t(9.05) = 8.58, P < 0.0001 | ||
28 | 23.6 | 6–42 | 0.3 | 0–2 | 98.7 | t(9.06) = 6.27, P = 0.0001 | ||
35 | 23.1 | 6–45 | 0.7 | 0–2 | 97.0 | t(9) = 6.31, P = 0.0001 | ||
4 | Texas A&M Universityd | 2 | 35.1 | 11–50 | 0.3 | 0–2 | 99.1 | t(9.05) = 8.51, P < 0.0001 |
7 | 26.3 | 0–45 | 0.3 | 0–2 | 98.9 | t(9.04) = 5.43, P = 0.0004 | ||
14 | 33.9 | 14–54 | 0 | 0–0 | 100 | t(17) = 8.14, P < 0.0001 | ||
21 | 28.9 | 13–46 | 0.7 | 0–4 | 97.6 | t(9) = 7.24, P < 0.0001 | ||
28 | 25.0 | 13–37 | 2.4 | 0–15 | 90.4 | t(9) = 9.14, P < 0.0001 | ||
35 | 25.7 | 6–51 | 6.1 | 0–18 | 76.3 | t(9) = 5.23, P = 0.0005 |
aFirst infestation on Day -2. Subsequent infestations on Day 5, 12, 19, 26 and 33. Tick counts were conducted at 48 hours post-treatment and weekly re-infestation
bTreatment with placebo or Simparica Trio™ (minimum dose 1.2 mg/kg sarolaner, 24 µg/kg moxidectin and 5 mg/kg pyrantel (as pamoate salt)) occurred on Day 0
cColony originated from ticks field-collected in Stillwater, OK, USA, in 1991 and was last supplemented with wild-caught ticks ~ 15 months prior to study start
dColony originated from ticks field-collected in Refugio Co., TX, USA, in the mid-1980s and was last supplemented with wild-caught ticks ~ 2 years prior to study start